News | July 01, 2013

Growth in Cerebral Aneurysms Increases Risk of Rupture

Cerebral aneurysms of all sizes—even small ones below seven millimeters—are 12 times more likely to rupture if they are growing in size, according to a new study published online in the journal Radiology.

A cerebral aneurysm is a balloon-like bulge in a weakened blood vessel in the brain. If an aneurysm ruptures, blood is leaked into or around the brain, which can cause brain damage or death.

According to The Brain Aneurysm Foundation, an estimated 6 million people in the United States have an unruptured brain aneurysm, or 1 in 50 people. Ruptured brain aneurysms occur in approximately 30,000 Americans each year and are fatal in about 40 percent of cases. Of those who survive, about two-thirds suffer some permanent neurological deficit.

“Given what a devastating event a ruptured brain aneurysm is, we are very motivated to identify the real risk factors for rupture,” said the study’s lead author, J. Pablo Villablanca, M.D., chief of diagnostic neuroradiology at the David Geffen School of Medicine at the University of California, Los Angeles.

In Villablanca’s study, 258 asymptomatic cerebral aneurysms identified either incidentally or during a baseline study of 165 patients (132 women, 33 men) were monitored over time (mean of 2.24 years) with computed tomography angiography (CTA), a noninvasive imaging study of the brain’s blood vessels. Patients were scanned with CTA at intervals of six or 12 months.

Over the study period, the researchers observed growth in 46 or nearly 18 percent of all the intracranial aneurysms in a total of 38 patients. Three of the 39 growing saccular aneurysms ruptured, and of those, all were less than seven millimeters in size at study entry.

“Our study shows that the size of the aneurysm is not as important as was once thought,” Dr. Villablanca said. “Any aneurysm is potentially capable of growth and thus requires follow-up imaging.”

Current guidelines based on research conducted by the International Study of Unruptured Intracranial Aneurysms and other studies suggest that known aneurysms less than seven millimeters in size have a low risk of rupture and do not need to be monitored with imaging.

Compared to the aneurysms that stayed the same size, the 46 growing aneurysms in the study were associated with a 12-fold higher risk of rupture. The researchers calculated the risk of rupture for growing aneurysms at 2.4 percent per patient-year, versus 0.2 percent for aneurysms without growth.

“Our data support the need to perform longitudinal follow-up imaging to monitor for possible growth in all incidental unruptured aneurysms, including small lesions,” Dr. Villablanca said.

The researchers also found that tobacco smoking and the initial size of the aneurysm were independent predictors of aneurysm growth. Together, these risk factors were associated with 78.4 percent of all aneurysm growth in the study.

“The positive association between aneurysm growth, aneurysm size, and cigarette smoking suggests that the combination of these factors are associated with an increased risk of rupture and may influence the need for therapeutic intervention,” Dr. Villablanca said.

Observation was the treatment of choice for 194 of 212 (91 percent) stable aneurysms. When aneurysm growth was discovered by CTA imaging, 50 percent of the growing aneurysms were treated, while the remaining 50 percent continued to be observed.###

“The Natural History of Asymptomatic Unruptured Cerebral Aneurysms Evaluated at CT Angiography: Growth and Rupture Incidence and Correlation with Epidemiologic Risk Factors.” Collaborating with Dr. Villablanca were Gary R. Duckwiler, M.D., Reza Jahan, M.D., Satoshi Tateshima, M.D., Ph.D., Neil A. Martin, M.D., John Frazee, M.D., Nestor R. Gonzalez, M.D., James Sayre, Ph.D., and Fernando V. Vinuela, M.D.

For more information: RSNA.org

Related Content

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI. #SCCT #perfusionimaging 

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.

News | Computed Tomography (CT) | March 16, 2020
March 16, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) released a new...
New ESC Guideline Provides Class 1 Recommendation for Coronary CTA
News | CT Angiography (CTA) | September 17, 2019
The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary...
Videos | CT Angiography (CTA) | August 07, 2019
This is a quick walk around of the new Siemens Somatom Go.top cardiovascular edition compact computed tomography (CT)
Videos | CT Angiography (CTA) | August 07, 2019
This is a quick walk around of the GE Healthcare Cardiographe dedicated cardiac CT system on display at the...
Artificial Intelligence Improves Heart Attack Risk Assessment
News | CT Angiography (CTA) | August 06, 2019
When used with a common heart scan, machine learning, a type of artificial intelligence (AI), does better than...